The TME is a dynamic system orchestrated by complex components, including stromal cells, CD4+ and CD8+ T cells, natural killer (NK) cells, tumor-related endothelial cells, cancer-associated fibroblasts (CAFs), and tumor-associated macrophages (TAMs) [3,4]. The gene discussed is CD4; the disease is neoplasm.